Glenmede Trust’s Alteryx Inc AYX Stock Holding History

Glenmede Trust’s Portfolio AYX Stock Details AYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15	Closed	-$1K	–	2366
2020 Q3	$1K	Sell	15 -400	-96%	-$54.5K	﹤0.01%	2418
2020 Q2	$67K	Buy	+415	New	+$53.8K	﹤0.01%	1253
2019 Q4	–	Sell	-348	Closed	-$37	–	3151
2019 Q3	$37	Sell	348 -352	-50%	-$43.7K	﹤0.01%	1800
2019 Q2	$76	Buy	+700	New	+$63.7K	﹤0.01%	1502

Other funds holding AYX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BCM

Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Glenmede Trust's AYX Position: Q4 2020 in Review

Glenmede Trust sold out of Alteryx Inc (AYX) in Q4 2020, closing a stake of 15 shares — an estimated $1K sold.

Glenmede Trust first reported a position in AYX in Q2 2019 and held it in 4 quarters. The position peaked at $67K in Q2 2020. 383 funds tracked by Wall St. Rank hold AYX as of Q4 2020.

Glenmede Trust reported no remaining Alteryx Inc position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 15 Alteryx Inc shares in Q4 2020, an estimated $1K.
Glenmede Trust first reported a position in Alteryx Inc in Q2 2019 and held it in 4 quarters.
Glenmede Trust's Alteryx Inc position peaked at $67K in Q2 2020.
383 funds tracked by Wall St. Rank held Alteryx Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.